Showing results (411-420 of 417) with videos related to
Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 417 results.
Heart (British Cardiac Society)|December 1, 2011
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary interventionD A Jones, K S Rathod, N Sekhri, et al.The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosisM W Lark, G B Stroup, S M Hwang, et al.Infection|October 2, 2015
Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory responseJ M Bordon, R Fernandez-Botran, T L Wiemken, et al.Journal of Medicinal Chemistry|November 2, 2001
Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockersJ Lloyd, J B Schmidt, G Rovnyak, et al.Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.Pageof 42